185 related articles for article (PubMed ID: 33866994)
1. Evidence of an interaction between
Rampino A; Torretta S; Gelao B; Veneziani F; Iacoviello M; Marakhovskaya A; Masellis R; Andriola I; Sportelli L; Pergola G; Minelli A; Magri C; Gennarelli M; Vita A; Beaulieu JM; Bertolino A; Blasi G
Eur Psychiatry; 2021 Apr; 64(1):e39. PubMed ID: 33866994
[TBL] [Abstract][Full Text] [Related]
2. The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.
Bureau A; Beaulieu JM; Paccalet T; Chagnon YC; Maziade M
J Affect Disord; 2017 Apr; 213():172-177. PubMed ID: 28242499
[TBL] [Abstract][Full Text] [Related]
3. Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission.
Khlghatyan J; Evstratova A; Chamberland S; Marakhovskaia A; Bahremand A; Toth K; Beaulieu JM
Front Mol Neurosci; 2018; 11():119. PubMed ID: 29706865
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.
Calabrò M; Porcelli S; Crisafulli C; Wang SM; Lee SJ; Han C; Patkar AA; Masand PS; Albani D; Raimondi I; Forloni G; Bin S; Mattiaccio A; Mantovani V; Jun TY; Pae CU; Serretti A
Adv Ther; 2017 Jun; 34(6):1482-1497. PubMed ID: 28508933
[TBL] [Abstract][Full Text] [Related]
5. FXR1P is a GSK3β substrate regulating mood and emotion processing.
Del'Guidice T; Latapy C; Rampino A; Khlghatyan J; Lemasson M; Gelao B; Quarto T; Rizzo G; Barbeau A; Lamarre C; Bertolino A; Blasi G; Beaulieu JM
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4610-9. PubMed ID: 26240334
[TBL] [Abstract][Full Text] [Related]
6. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.
Pergola G; Di Carlo P; D'Ambrosio E; Gelao B; Fazio L; Papalino M; Monda A; Scozia G; Pietrangelo B; Attrotto M; Apud JA; Chen Q; Mattay VS; Rampino A; Caforio G; Weinberger DR; Blasi G; Bertolino A
Transl Psychiatry; 2017 Jan; 7(1):e1006. PubMed ID: 28094815
[TBL] [Abstract][Full Text] [Related]
7. Effects of Glycogen Synthase Kinase-3 Beta Gene Polymorphisms on the Plasma Concentration of Aripiprazole in Chinese Patients with Schizophrenia: A Preliminary Study.
Xu Z; Wen C; Huang Y; Yuan Q; Zhang X; Lin D; Liu L; Wang W
J Mol Neurosci; 2023 Jan; 73(1):76-83. PubMed ID: 36539584
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic Mis-splicing of CPEB4 in Schizophrenia.
Ollà I; Pardiñas AF; Parras A; Hernández IH; Santos-Galindo M; Picó S; Callado LF; Elorza A; Rodríguez-López C; Fernández-Miranda G; Belloc E; Walters JTR; O'Donovan MC; Méndez R; Toma C; Meana JJ; Owen MJ; Lucas JJ
Biol Psychiatry; 2023 Aug; 94(4):341-351. PubMed ID: 36958377
[TBL] [Abstract][Full Text] [Related]
9. FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors.
Shen M; Guo Y; Dong Q; Gao Y; Stockton ME; Li M; Kannan S; Korabelnikov T; Schoeller KA; Sirois CL; Zhou C; Le J; Wang D; Chang Q; Sun QQ; Zhao X
Mol Psychiatry; 2021 Nov; 26(11):6845-6867. PubMed ID: 33863995
[TBL] [Abstract][Full Text] [Related]
10. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
Yu H; Yan H; Wang L; Li J; Tan L; Deng W; Chen Q; Yang G; Zhang F; Lu T; Yang J; Li K; Lv L; Tan Q; Zhang H; Xiao X; Li M; Ma X; Yang F; Li L; Wang C; Li T; Zhang D; Yue W;
Lancet Psychiatry; 2018 Apr; 5(4):327-338. PubMed ID: 29503163
[TBL] [Abstract][Full Text] [Related]
11. The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants.
Toro VD; Antonucci LA; Quarto T; Passiatore R; Fazio L; Ursini G; Chen Q; Masellis R; Torretta S; Sportelli L; Kikidis GC; Massari F; D'Ambrosio E; Rampino A; Pergola G; Weinberger DR; Bertolino A; Blasi G
Psychol Med; 2024 Jun; 54(8):1876-1885. PubMed ID: 38305128
[TBL] [Abstract][Full Text] [Related]
12. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; Wong AH; Kennedy JL
Psychopharmacology (Berl); 2008 Oct; 200(2):177-86. PubMed ID: 18500637
[TBL] [Abstract][Full Text] [Related]
13. Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.
Calabrò M; Porcelli S; Crisafulli C; Wang SM; Lee SJ; Han C; Patkar AA; Masand PS; Albani D; Raimondi I; Forloni G; Bin S; Cristalli C; Mantovani V; Pae CU; Serretti A
J Mol Neurosci; 2018 Jan; 64(1):62-74. PubMed ID: 29164477
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
Weng S; Wang B; Li M; Chao S; Lin R; Zheng R; Yu Y; Guo S; Lin X
PLoS One; 2021; 16(4):e0249997. PubMed ID: 33914752
[TBL] [Abstract][Full Text] [Related]
15. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
[TBL] [Abstract][Full Text] [Related]
16. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive family-based replication study of schizophrenia genes.
Aberg KA; Liu Y; Bukszár J; McClay JL; Khachane AN; Andreassen OA; Blackwood D; Corvin A; Djurovic S; Gurling H; Ophoff R; Pato CN; Pato MT; Riley B; Webb T; Kendler K; O'Donovan M; Craddock N; Kirov G; Owen M; Rujescu D; St Clair D; Werge T; Hultman CM; Delisi LE; Sullivan P; van den Oord EJ
JAMA Psychiatry; 2013 Jun; 70(6):573-81. PubMed ID: 23894747
[TBL] [Abstract][Full Text] [Related]
18. Fxr1 regulates sleep and synaptic homeostasis.
Khlghatyan J; Evstratova A; Bozoyan L; Chamberland S; Chatterjee D; Marakhovskaia A; Soares Silva T; Toth K; Mongrain V; Beaulieu JM
EMBO J; 2020 Nov; 39(21):e103864. PubMed ID: 32893934
[TBL] [Abstract][Full Text] [Related]
19. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
Li J; Yoshikawa A; Brennan MD; Ramsey TL; Meltzer HY
Schizophr Res; 2018 Feb; 192():194-204. PubMed ID: 28431800
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
